PriceTargets.com logo

Everbridge - EVBG Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $35.00
  • Forecasted Upside: 0.00%
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$35.00 As of 08/19/2024 01:00 AM ET
+0 (0.00%)
Get New Everbridge Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EVBG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EVBG

Analyst Price Target is $35.00
This price target is based on 7 analysts offering 12 month price targets for Everbridge in the last 3 months. The average price target is $35.00, with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 0.00% upside from the last price of $35.00.

This chart shows the closing price for EVBG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 7 investment analysts is to hold stock in Everbridge. This rating has held steady since October 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
6/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/25/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
12/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
3/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
6/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
9/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
11/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
12/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/14/2024Robert W. BairdBoost TargetNeutral ➝ Neutral$29.00 ➝ $35.00
5/13/2024Needham & Company LLCReiterated RatingHold
3/4/2024Canaccord Genuity GroupBoost TargetHold ➝ Hold$28.60 ➝ $35.00
3/4/2024Truist FinancialBoost TargetHold ➝ Hold$20.00 ➝ $35.00
2/7/2024Raymond JamesReiterated RatingOutperform ➝ Market Perform
2/6/2024Robert W. BairdBoost TargetNeutral ➝ Neutral$21.00 ➝ $29.00
2/6/2024Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight
2/5/2024William BlairDowngradeOutperform ➝ Market Perform
2/5/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Hold$28.60
2/5/2024Needham & Company LLCReiterated RatingBuy ➝ Hold
12/20/2023Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight
11/10/2023William BlairReiterated RatingOutperform
11/10/2023Raymond JamesLower TargetOutperform ➝ Outperform$30.00 ➝ $24.00
11/10/2023Truist FinancialLower TargetHold ➝ Hold$23.00 ➝ $20.00
11/10/2023The Goldman Sachs GroupLower TargetSell ➝ Sell$27.00 ➝ $23.00
8/9/2023Raymond JamesLower TargetOutperform ➝ Outperform$34.00 ➝ $30.00
8/9/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$35.00
8/9/2023StephensLower TargetEqual Weight ➝ Equal Weight$30.00 ➝ $26.00
8/9/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$27.00 ➝ $25.00
7/11/2023Needham & Company LLCUpgradeHold ➝ Buy$35.00
5/10/2023Truist FinancialLower Target$32.00 ➝ $27.00
5/10/2023Robert W. BairdLower Target$34.00 ➝ $28.00
5/10/2023BarclaysLower Target$32.00 ➝ $27.00
4/21/2023StephensDowngradeOverweight ➝ Equal Weight$41.00 ➝ $34.00
2/23/2023StephensBoost Target$38.00 ➝ $41.00
2/17/2023Raymond JamesBoost TargetOutperform$32.00 ➝ $39.00
1/6/2023Wells Fargo & CompanyLower TargetEqual Weight$32.00 ➝ $28.00
12/14/2022Wells Fargo & CompanyBoost Target$32.00
11/9/2022Canaccord Genuity GroupLower Target$55.00 ➝ $40.00
11/9/2022Raymond JamesLower TargetOutperform$38.00 ➝ $32.00
8/30/2022Truist FinancialBoost TargetHold$31.00 ➝ $38.00
8/26/2022Stifel NicolausBoost TargetHold$32.00 ➝ $38.00
8/11/2022Canaccord Genuity GroupLower Target$59.00 ➝ $55.00
8/10/2022Raymond JamesLower Target$45.00 ➝ $38.00
8/10/2022Truist FinancialLower TargetHold$42.00 ➝ $31.00
7/25/2022Stifel NicolausLower Target$40.00 ➝ $32.00
7/25/2022BarclaysLower TargetEqual Weight$40.00 ➝ $32.00
2/28/2022BarclaysLower TargetEqual Weight$60.00 ➝ $40.00
2/25/2022Bank of AmericaLower TargetUnderperform$75.00 ➝ $30.00
2/25/2022StephensLower TargetOverweight$200.00 ➝ $58.00
2/25/2022Stifel NicolausLower TargetHold$100.00 ➝ $40.00
2/25/2022Wells Fargo & CompanyLower TargetEqual Weight$50.00 ➝ $36.00
2/25/2022Canaccord Genuity GroupLower Target$178.00 ➝ $59.00
2/25/2022Truist FinancialDowngradeBuy ➝ Hold$85.00 ➝ $42.00
2/25/2022Raymond JamesLower TargetOutperform$80.00 ➝ $50.00
1/26/2022Wells Fargo & CompanyLower TargetEqual Weight$65.00 ➝ $50.00
1/24/2022BarclaysLower TargetEqual Weight$90.00 ➝ $60.00
12/27/2021Truist FinancialLower TargetBuy$185.00 ➝ $85.00
12/17/2021Raymond JamesLower TargetOutperform$180.00 ➝ $80.00
12/16/2021The Goldman Sachs GroupInitiated CoverageSell$55.00
12/13/2021Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$125.00 ➝ $65.00
12/10/2021Raymond JamesReiterated RatingBuy$179.00
12/10/2021Northland SecuritiesDowngradeOutperform ➝ Market Perform
12/10/2021Needham & Company LLCDowngradeBuy ➝ Hold
12/10/2021Bank of AmericaDowngradeNeutral ➝ Underperform$175.00 ➝ $100.00
12/10/2021BarclaysDowngradeOverweight ➝ Equal Weight$185.00 ➝ $90.00
12/10/2021Stifel NicolausDowngradeBuy ➝ Hold$185.00 ➝ $100.00
12/10/2021Robert W. BairdDowngradeOutperform ➝ Neutral$175.00 ➝ $95.00
12/10/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$200.00 ➝ $127.00
11/22/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$125.00
11/10/2021StephensBoost TargetOverweight$180.00 ➝ $200.00
11/10/2021Robert W. BairdBoost TargetOutperform$170.00 ➝ $175.00
10/20/2021BarclaysInitiated CoverageOverweight$185.00
9/7/2021Stifel NicolausBoost TargetBuy$175.00 ➝ $185.00
8/10/2021Needham & Company LLCReiterated RatingBuy$175.00
8/10/2021Raymond JamesBoost TargetOutperform$140.00 ➝ $180.00
8/10/2021StephensBoost TargetOverweight$165.00 ➝ $180.00
8/10/2021Stifel NicolausUpgradeBuy$160.00 ➝ $175.00
5/11/2021Raymond JamesLower TargetOutperform$165.00 ➝ $140.00
4/7/2021Needham & Company LLCReiterated RatingBuy$175.00
3/29/2021Credit Suisse GroupReiterated RatingNeutral$145.00
2/19/2021Northland SecuritiesBoost Target$155.00 ➝ $165.00
2/19/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$200.00
1/15/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral$145.00
10/28/2020Bank of AmericaDowngradeBuy ➝ Neutral$162.00 ➝ $150.00
8/7/2020Needham & Company LLCReiterated RatingBuy
8/7/2020Raymond JamesBoost TargetOutperform$130.00 ➝ $165.00
8/7/2020Credit Suisse GroupBoost TargetOutperform$118.00 ➝ $145.00
7/20/2020OppenheimerReiterated RatingBuy$119.00 ➝ $180.00
6/12/2020Northland SecuritiesInitiated CoverageBuy$143.00
5/20/2020Stifel NicolausBoost TargetBuy$130.00 ➝ $160.00
5/20/2020Needham & Company LLCBoost TargetBuy$135.00 ➝ $175.00
5/6/2020SunTrust BanksBoost TargetBuy$133.00 ➝ $143.00
5/6/2020Robert W. BairdBoost TargetOutperform$120.00 ➝ $132.00
5/6/2020JPMorgan Chase & Co.Boost TargetNeutral$98.00 ➝ $115.00
5/6/2020Credit Suisse GroupBoost TargetOutperform$95.00 ➝ $118.00
5/6/2020Raymond JamesBoost TargetOutperform$105.00 ➝ $130.00
5/6/2020OppenheimerReiterated RatingBuy$119.00
3/24/2020StephensBoost TargetOverweight$115.00 ➝ $120.00
3/24/2020SunTrust BanksBoost Target$115.00 ➝ $133.00
3/24/2020Stifel NicolausBoost TargetBuy$105.00 ➝ $130.00
3/24/2020Robert W. BairdReiterated RatingOutperform$110.00 ➝ $120.00
3/24/2020Needham & Company LLCBoost TargetBuy$115.00 ➝ $135.00
3/23/2020StephensReiterated RatingBuy$115.00
3/9/2020OppenheimerUpgradeMarket Perform ➝ Outperform$119.00
2/19/2020Stifel NicolausBoost TargetBuy$100.00 ➝ $105.00
2/19/2020SunTrust BanksBoost TargetOverweight ➝ Buy$100.00 ➝ $115.00
2/19/2020StephensBoost TargetOverweight$105.00 ➝ $115.00
2/19/2020Raymond JamesBoost TargetOutperform$100.00 ➝ $105.00
2/19/2020Credit Suisse GroupBoost TargetOutperform$90.00 ➝ $95.00
1/14/2020StephensReiterated RatingBuy$105.00
1/7/2020OppenheimerInitiated CoverageHold
(Data available from 12/18/2019 forward)

News Sentiment Rating

-1.49 (Sell)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
5/22/2024
  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/21/2024
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/21/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/20/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/18/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Everbridge logo
Everbridge, Inc. engages in the development of software solutions for critical event management and enterprise safety applications that automate and accelerate an organization's operational response to critical events. Its SaaS-based CEM platform enables customers to aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes, and track progress on executing response plans. The company was founded by Cinta Putra and Steve Kirchmeier in 2002 and is headquartered in Burlington, MA.
Read More

Today's Range

Now: $35.00
Low: $35.00
High: $35.00

50 Day Range

MA: $35.00
Low: $35.00
High: $35.00

52 Week Range

Now: $35.00
Low: $18.50
High: $36.31

Volume

448 shs

Average Volume

969,549 shs

Market Capitalization

$1.46 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98

Frequently Asked Questions

What sell-side analysts currently cover shares of Everbridge?

The following sell-side analysts have issued research reports on Everbridge in the last year: Canaccord Genuity Group Inc., Needham & Company LLC, Raymond James, Robert W. Baird, StockNews.com, Truist Financial Co., Wells Fargo & Company, and William Blair.
View the latest analyst ratings for EVBG.

What is the current price target for Everbridge?

0 Wall Street analysts have set twelve-month price targets for Everbridge in the last year. Their average twelve-month price target is $35.00. Truist Financial Co. has the highest price target set, predicting EVBG will reach $35.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $35.00 for Everbridge in the next year.
View the latest price targets for EVBG.

What is the current consensus analyst rating for Everbridge?

Everbridge currently has 7 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in EVBG, but not buy more shares or sell existing shares.
View the latest ratings for EVBG.

What other companies compete with Everbridge?

Other companies that are similar to Everbridge include Workiva, Science Applications International, Varonis Systems, Intapp and Kanzhun. Learn More about companies similar to Everbridge.

How do I contact Everbridge's investor relations team?

Everbridge's physical mailing address is 25 CORPORATE DRIVE SUITE 400, BURLINGTON MA, 01803. The technology company's listed phone number is (818) 230-9700 and its investor relations email address is [email protected]. The official website for Everbridge is www.everbridge.com. Learn More about contacing Everbridge investor relations.